Latest News

  • Alkermes to Present Data on ALKS 5461 at Upcoming Society of Biological Psychiatry Annual Meeting Read More
  • Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia Read More
  • Alkermes plc Reports First Quarter 2017 Financial Results Read More


Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes